MedPath

Uncontrolled Donation After Circulatory Determination of Death (uDCDD)

Completed
Conditions
Uncontrolled Donation After Circulatory Determination of Death
Registration Number
NCT03935230
Lead Sponsor
Université de Sherbrooke
Brief Summary

World-wide, patients waiting for organ transplantation exceed the number of organs available. Many European countries have a uDCDD program which contribute to 10-15% of the donor pool. In Canada, this type of program does not exist. The purpose of this study is to report how many deceased person fulfill the criteria for uncontrolled DCDD in a Canadian medical center.

Detailed Description

While transplantation has become the definitive treatment for many people suffering end-stage organ failure, demand exceeds supply. For many years, donation after neurological death represented the principal source of organs for transplantation. In the last decade, prevention measures, improvements in neurocritical care, and decompressive craniectomy have led to a significant decrease in the number of non-directed donors (NDDs). In such situations, alternative sources for organ donation must be identified. Cardiac-arrest patients could provide a solution to this organ shortage. Patients who have experienced unexpected in or out of hospital cardiopulmonary arrest could become organ donors. Organ donation following uncontrolled cardiocirculatory death is currently practiced in many European countries. However, in Canada, it's not yet authorized. Yet, each deceased could save up to four lives. The purpose of this study is to determine the organ potential for a cohort of patient who had died from a cardiopulmonary arrest at the CHUS in 2015 and assess the effect of the implementation of a uDCD program on the number of additional donors.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1111
Inclusion Criteria
  • All patients treated for cardiocirculatory arrest at the CIUSSS-Estrie CHUS in 2015.
Exclusion Criteria
  • Patients with a status of no resuscitation
  • Pediatric patients (<18 years old)
  • Adults >65 years old

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Potential contribution of a uDCDD program on the number of additional donors.1 year

Defined as (must meet all criteria):

* Age ≤70 years old

* Absence of obvious cause of death (rigor mortis, decapitation, overwhelming traumatic injury)

* Absence of surgical cause of cardiac arrest

* No sign of IV drug abuse

* No history of malignancies

Secondary Outcome Measures
NameTimeMethod
Areas of future research.1 year

Areas of future research.

Number of tissus donors1 year

Number of tissus donors

Effect of the implementation of a uDCDD program on the number of additional organs suitable for transplantation.1 year

Effect of the implementation of a uDCDD program on the number of additional organs suitable for transplantation.

Potential obstacles and solutions related to the implementation of a uDCDD program in Canada.1 year

Potential obstacles and solutions related to the implementation of a uDCDD program in Canada.

© Copyright 2025. All Rights Reserved by MedPath